Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 1250.00 | 830.55 | 1526.00 | 1922.63 | 0.7937 | 0.6526 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2194.00 | 1922.63 | 1.1411 | 1.2304 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 638.00 | 1922.63 | 0.3318 | -0.1957 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 406.00 | 1922.63 | 0.2112 | -0.4463 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1623.00 | 1922.63 | 0.8442 | 0.7389 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1791.00 | 1922.63 | 0.9315 | 0.8862 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1092.00 | 1922.63 | 0.5680 | 0.2536 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 571.00 | 1922.63 | 0.2970 | -0.2661 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1861.50 | 1922.63 | 0.9682 | 0.9473 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3775.00 | 3777.75 | 0.9993 | 0.9986 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3666.00 | 3777.75 | 0.9704 | 0.9421 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3947.00 | 3777.75 | 1.0448 | 1.0877 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 3899.00 | 3777.75 | 1.0321 | 1.0628 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 4161.00 | 3777.75 | 1.1014 | 1.1985 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3446.00 | 3777.75 | 0.9122 | 0.8279 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 1801.00 | 3777.75 | 0.4767 | -0.0318 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 2030.00 | 3777.75 | 0.5374 | 0.0886 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1861.36 | 4239.00 | 3777.75 | 1.1221 | 1.2388 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4395.00 | 3777.75 | 1.1634 | 1.3195 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1514.00 | 3777.75 | 0.4008 | -0.1831 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4140.00 | 3777.75 | 1.0959 | 1.1876 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1609.00 | 3777.75 | 0.4259 | -0.1330 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4254.00 | 3777.75 | 1.1261 | 1.2466 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3406.00 | 3777.75 | 0.9016 | 0.8071 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4130.00 | 3777.75 | 1.0932 | 1.1824 |